LINC02533

Across TCGA pan-cancer cohorts, LINC02533 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC02533’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02533 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02533 is over-expressed in tumor.

BRCA, COAD, and PAAD are the cancer types where LINC02533 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02533 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.113	<.001	6	view →
COAD	Female	All	+0.115	<.001	5	view →
PAAD	Male	All	+0.080	.015	2	view →
KIRC	All	All	+0.010	.021	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC02533–BRCA

Open the BRCA breakdown →